Panel Discussion: Paving Towards Strategic Drug-Diagnostic Market Entry Across APAC – From Trial Design to Commercial Success
- What are the CDx policies and regulations across APAC, and how can we address critical bottlenecks regarding regulatory adherence and commercialization?
- Which CDx strategies and testing models are optimal for maximizing market patient access across APAC, and how does this differ per region? And across indications?